Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Miranda Boyun Lam, M.D.

Concepts (161)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Radiation Oncology520235551.950 Why?
Medicare14202465661.240 Why?
Neoplasms122023216831.000 Why?
Insurance Coverage4202219010.800 Why?
Medicaid5202227360.790 Why?
Insurance Carriers120221570.760 Why?
Medical Oncology3202322650.750 Why?
Prospective Payment System120211330.740 Why?
Health Care Costs3202332090.690 Why?
Radiotherapy3202115330.680 Why?
Patient Protection and Affordable Care Act4202212090.630 Why?
Retroperitoneal Neoplasms120213400.620 Why?
Hemangiosarcoma120202390.610 Why?
Hospice Care220226720.600 Why?
Health Expenditures3202123480.600 Why?
Accreditation120184500.530 Why?
United States242024698720.530 Why?
Vulnerable Populations120216870.530 Why?
Medically Uninsured120218530.520 Why?
Healthcare Disparities5202331580.470 Why?
Hospitals5202439520.460 Why?
Terminal Care2202116940.390 Why?
Health Status Disparities1202317970.390 Why?
Quality Indicators, Health Care1202118310.380 Why?
Patient Admission1201813800.380 Why?
Lung Neoplasms52024131020.380 Why?
Delivery of Health Care4202453190.380 Why?
Sarcoma1202118970.350 Why?
Carcinoma, Non-Small-Cell Lung3202452210.330 Why?
Surgical Procedures, Operative1202018760.330 Why?
Uterine Cervical Neoplasms1202120200.330 Why?
Lymph Nodes1202034740.320 Why?
Quality Assurance, Health Care1201822120.310 Why?
Fee-for-Service Plans320216940.290 Why?
Death220226780.290 Why?
Neoplasm Staging72024110310.270 Why?
Private Practice220211540.250 Why?
Humans4420247443430.230 Why?
Aged1820241632800.220 Why?
Radiotherapy Planning, Computer-Assisted4202316240.220 Why?
Telephone120166170.210 Why?
National Cancer Institute (U.S.)120222880.190 Why?
Colonic Neoplasms2202325410.190 Why?
Combined Modality Therapy3202186420.190 Why?
Colorectal Neoplasms1202067730.190 Why?
Skin Neoplasms1202056860.190 Why?
Radiotherapy Dosage3202328790.180 Why?
Chondrosarcoma120233090.180 Why?
Pancreatic Neoplasms3202352560.180 Why?
Health Services Accessibility3202251370.180 Why?
Retreatment120216100.170 Why?
Career Choice120157440.170 Why?
Cost Savings220219260.170 Why?
Terminally Ill120212380.170 Why?
Medicare Part D120233280.170 Why?
Ownership120213320.160 Why?
Eligibility Determination120224030.160 Why?
Joint Commission on Accreditation of Healthcare Organizations12018930.160 Why?
Quality of Health Care2202143710.160 Why?
Rural Health Services120213790.150 Why?
Scalp120203800.150 Why?
Carcinoma in Situ120238060.150 Why?
Radiosurgery2202313290.150 Why?
Ambulatory Care Facilities120239330.140 Why?
Databases, Factual2202077290.140 Why?
Patients120239000.140 Why?
Reimbursement, Incentive120215400.130 Why?
Spinal Neoplasms120237600.130 Why?
Cross-Sectional Studies32021250430.130 Why?
Postoperative Period1202018420.130 Why?
Leukemia1202315110.130 Why?
Rectal Neoplasms1201412060.120 Why?
Gastrointestinal Neoplasms120229900.120 Why?
Logistic Models22020134080.120 Why?
Coronary Artery Bypass1202422890.120 Why?
Confidence Intervals1201929710.120 Why?
Hawaii220231050.110 Why?
Breast Neoplasms12020208220.110 Why?
Female1220233801940.110 Why?
International Classification of Diseases120188670.110 Why?
Lymphoma, Non-Hodgkin1202013810.110 Why?
Inpatients1202325180.100 Why?
Kallikreins120132580.100 Why?
Internship and Residency2201557880.100 Why?
Disease Management1202124590.090 Why?
Male1120213501180.090 Why?
Insurance, Health1202224940.090 Why?
Linear Models1201959520.090 Why?
Biopsy1202167560.080 Why?
Mortality1202028640.080 Why?
Retrospective Studies92024774490.080 Why?
Survival Rate22021127880.080 Why?
Small Cell Lung Carcinoma120133880.080 Why?
Fluorodeoxyglucose F182201320160.080 Why?
Positron-Emission Tomography2201362340.070 Why?
Clinical Trials as Topic1201379130.070 Why?
Middle Aged820222133830.070 Why?
Diagnostic Imaging1202135070.070 Why?
Liver Neoplasms1202242530.070 Why?
Palliative Care1202134930.070 Why?
Aged, 80 and over42019577760.070 Why?
Leadership1201513570.070 Why?
Follow-Up Studies42021390500.060 Why?
Odds Ratio1201898490.060 Why?
Neoplasm Recurrence, Local4202092390.060 Why?
Adenocarcinoma2202063640.060 Why?
Longitudinal Studies12020139890.060 Why?
Head and Neck Neoplasms1201827340.060 Why?
Prognosis32021290630.060 Why?
Prostate-Specific Antigen1201324940.060 Why?
Diagnosis-Related Groups120244550.050 Why?
Curriculum1201536050.050 Why?
Hematopoietic Stem Cell Transplantation1202054420.050 Why?
Treatment Outcome42021631140.050 Why?
Prevalence12018152260.050 Why?
Radiotherapy, Adjuvant1201417700.040 Why?
Brachytherapy1201512480.040 Why?
Qualitative Research1201626820.040 Why?
Postoperative Care1201414860.040 Why?
Pneumonectomy1202410940.040 Why?
Costs and Cost Analysis1202316810.040 Why?
Pancreaticoduodenectomy120205030.040 Why?
Antineoplastic Agents12019136950.030 Why?
Nasopharyngeal Neoplasms120182860.030 Why?
Spine1202311440.030 Why?
Pancreatectomy120208040.030 Why?
Chemotherapy, Adjuvant1201434790.030 Why?
Adult520222140550.030 Why?
Multivariate Analysis22023122450.030 Why?
Transplantation, Autologous1202021240.030 Why?
Preoperative Care1201422500.030 Why?
Cardiovascular Diseases12020151650.030 Why?
Breast1202319690.030 Why?
Societies, Medical1201537430.030 Why?
Radiopharmaceuticals2201326450.030 Why?
Radiometry120188000.030 Why?
Carcinoma, Large Cell120131130.030 Why?
Magnetic Resonance Spectroscopy1202337600.030 Why?
Radiotherapy, Intensity-Modulated120188060.030 Why?
Radiation Injuries1201811800.020 Why?
Stents1202332800.020 Why?
Tomography, X-Ray Computed12013201290.020 Why?
Prostatic Neoplasms12013111240.020 Why?
Echocardiography1202351020.020 Why?
Biomedical Research1201533090.020 Why?
Survival Analysis12023102520.020 Why?
Neoadjuvant Therapy1202027280.020 Why?
Disease-Free Survival1202068950.020 Why?
Neoplasm Metastasis1201848510.020 Why?
Kaplan-Meier Estimate1201865380.020 Why?
Cohort Studies22022405610.020 Why?
Lymphatic Metastasis1201329240.020 Why?
Time Factors12016400750.010 Why?
Hospitalization12023102620.010 Why?
Models, Statistical1201851020.010 Why?
Antineoplastic Combined Chemotherapy Protocols12020115240.010 Why?
Proportional Hazards Models12013123540.010 Why?
Carcinoma, Squamous Cell1201340340.010 Why?
Young Adult12018564300.010 Why?
Adolescent12018857810.010 Why?
Prospective Studies12013532880.010 Why?
Lam's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (161)
Explore
_
Co-Authors (54)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.